Explore more publications!

Press Releases

STAND UP FOR SCIENCE TO HOLD 'RALLY TO TAKE BACK SCIENCE' TOMORROWE IN 48 LOCATIONS NATIONWIDE
Houzeo Publishes a Hyde Park Neighborhood Guide to Simplify Home Search in Chicago
Chicago Home Tutor Celebrates National Reading Month by Expanding Access to Personalized Reading Tutor Services Across Chicagoland
Catalyst Pharmaceuticals to Showcase Real‑World Findings in Duchenne Muscular Dystrophy and Host Vamorolone-Focused Symposium at the 2026 MDA Clinical & Scientific Conference
Grundfos Reintroduces Modernized Yeomans Chicago Corporation Portfolio to Address Modern Global Wastewater Challenges
Diamond Equity Research Releases Update Note on MAIA Biotechnology, Inc. (NYSE: MAIA)
The SBB Research Group Foundation Sponsors World Wildlife Fund
Independent Peterson Health Technology Institute evaluation validates impact of Cylinder Health’s digestive care model
Basketball Museum of Illinois Names Dr. Jason Ronai Executive Director and Joe Dondanville Chief Development Officer
Actuate Therapeutics to Present at The Citizens Life Sciences Conference
MAIA Biotechnology Announces Closing of $30 Million Underwritten Public Offering of Common Stock
The SBB Research Group Foundation Sponsors The Dragonfly Foundation
REP JAMIE RASKIN AND GEORGE CONWAY TO SPEAK AT 'RALLY TO TAKE BACK SCIENCE' ON MARCH 7TH IN WASHINGON D.C.
K9 University Chicago CEO Mariya Sergeeva Named One of the Top 5 Entrepreneurs to Watch in 2026
MEDIA ADVISORY: STAND UP FOR SCIENCE TO HOLD 'RALLY TO TAKE BACK SCIENCE' IN 46 LOCATIONS NATIONWIDE ON MARCH 7th 2026
B2B Technology Market Forecast to Grow 3% in 2026 Following Positive Close to 2025, Reports Circana
MAIA Biotechnology Announces Proposed Underwritten Public Offering of Common Stock and Pre-Funded Warrants
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Boston Scientific Corporation - BSX
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Ostin Technology Group Co., Ltd. of Class Action Lawsuit and Upcoming Deadlines – OST
MAIA Biotechnology Announces Pricing of $30 Million Underwritten Public Offering of Common Stock

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions